Delaet Ingrid
Chief Regulatory Officer
Delaet Ingrid has filed 6 SEC Form 4 filings (22 transaction rows) across 1 company, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Sep 15, 2026.
On the most recent filing, Delaet Ingrid is listed as Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC. Inside the rolling window, Delaet Ingrid reported no open-market purchases and 5 open-market sales totaling $3.7M in NBIX. The largest disclosed transaction in the window is a sale of 8,433 NBIX shares on Jul 9, 2026, worth $1.5M.
Companies traded
Other insiders at NBIX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Delaet Ingrid made?
Delaet Ingrid has filed 6 SEC Form 4 filings (22 transaction rows) across 1 company since 2026.
Which companies does Delaet Ingrid trade?
Delaet Ingrid has filed SEC Form 4 disclosures for 1 company, including NBIX.
When was Delaet Ingrid's most recent SEC Form 4 filing?
Delaet Ingrid's most recent SEC Form 4 filing on Tracefour is dated Sep 15, 2026.
What is Delaet Ingrid's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Delaet Ingrid is listed as Chief Regulatory Officer.
What is Delaet Ingrid's total buy and sell value in the current window?
Inside the rolling retention window, Delaet Ingrid bought $0 and sold $3.7M based on SEC Form 4 filings.
What was Delaet Ingrid's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 8,433 NBIX shares on 2026-07-09, worth $1.5M, per SEC Form 4 filings.